Teriparatide,PTH 1-34,hPTH (1-34),Human parathyroid hormone-(1-34)
>99%
- Product Code: 105963
CAS:
52232-67-4
| Molecular Weight: | 4117.72 g./mol | Molecular Formula: | C₁₈₁H₂₉₁N₅₅O₅₁S₂ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C |
Product Description:
Used primarily in the treatment of osteoporosis, particularly in postmenopausal women and men at high risk of fracture. It works by stimulating bone formation, increasing bone mineral density, and reducing the risk of fractures. It is also employed in cases where other osteoporosis treatments have failed or are not suitable. Additionally, it is used for the management of hypoparathyroidism, helping to regulate calcium and phosphate levels in the blood. Administered via subcutaneous injection, it is typically prescribed for a limited duration due to potential long-term risks.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | White Powder |
| Purity (%) | 99-100 |
| Soluble In Water | Conforms |
| Specific Optical Rotation (C=0.5,1%HAc) | -75.0--65.0 |
| Acetate Content | 15 |
| Identification | Monoisotopic Mass:4117.7±2.0 |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | £180.48 |
+
-
|
| 0.025 | 10-20 days | £564.97 |
+
-
|
Teriparatide,PTH 1-34,hPTH (1-34),Human parathyroid hormone-(1-34)
Used primarily in the treatment of osteoporosis, particularly in postmenopausal women and men at high risk of fracture. It works by stimulating bone formation, increasing bone mineral density, and reducing the risk of fractures. It is also employed in cases where other osteoporosis treatments have failed or are not suitable. Additionally, it is used for the management of hypoparathyroidism, helping to regulate calcium and phosphate levels in the blood. Administered via subcutaneous injection, it is typically prescribed for a limited duration due to potential long-term risks.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
£0.00
£0.00
Total :